Recent research suggests that protective antibodies from Covid-19 vaccines, specifically the mRNA type, tend to decline ...
New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, ...
COVID-19 presents a broad range of symptoms, varying in intensity from mild to severe and even life-threatening.
Repeated mRNA vaccinations boost mucosal antibodies, improving defense against COVID-19. This may help enhance protection ...
COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, ...
A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...
A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally ...
For all the time and effort spent on temperature checking and other anecdotal inquiries for COVID symptoms—and with all its ...
It provides a more precise prediction than currently available of how serious the case is by focusing on autoantibodies in ...
A study published in the journal Frontiers of Medicine has found an association between the inactivated COVID-19 vaccine CoronaVac from Sinovac ... normal values for ADAMTS13 antigen and inhibitory ...